The Hindu Businessline

Cipla looks to ensure consistent drug supplies, as costs increase due to West Asia war, says MD & Global CEO

The companys net profit at Rs 555 crore for the quarter under review was down 55 per cent from Rs 1,222 crore in the same period last year